Related Experiment Videos
Hyperbaric bupivacaine for spinal analgesia
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
|February 27, 1982
Summary
Hyperbaric bupivacaine provided effective spinal anesthesia in most patients, with a good analgesic block lasting approximately 6.5 hours. This study found it satisfactory for anesthetic practice.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Spinal anesthesia is a common technique for surgical procedures.
- Assessing the efficacy and safety of anesthetic agents is crucial for patient care.
Purpose of the Study:
- To evaluate the efficacy of hyperbaric bupivacaine for spinal anesthesia.
- To determine the duration of action and side effects of hyperbaric bupivacaine.
Main Methods:
- An open, non-comparative trial involving 61 patients (ASA classification I-III).
- Administration of hyperbaric bupivacaine for spinal anesthesia.
- Monitoring of analgesic block quality, need for supplementary analgesia, and hemodynamic stability.
Main Results:
- A good quality analgesic block was achieved in 59 out of 61 patients.
- Two patients required supplementary analgesia and sedation.
- Four patients experienced hypotension, managed with fluid replacement.
- The mean duration of action for hyperbaric bupivacaine was approximately 6.5 hours.
Conclusions:
- Hyperbaric bupivacaine is an effective agent for spinal anesthesia.
- The drug demonstrated a satisfactory duration of action and manageable side effect profile.
- The findings support the use of hyperbaric bupivacaine in anesthetic practice.